本页面由Tiger Trade Technology Pte. Ltd.提供服务

Harmony Biosciences Holdings, Inc.

38.50
+0.35000.92%
盘前38.500.00000.00%07:00 EDT
成交量:48.61万
成交额:1,870.98万
市值:22.42亿
市盈率:12.46
高:38.93
开:38.13
低:37.48
收:38.15
52周最高:40.87
52周最低:25.52
股本:5,823.64万
流通股本:5,080.33万
量比:0.80
换手率:0.96%
股息:- -
股息率:- -
每股收益(TTM):3.09
每股收益(LYR):2.71
净资产收益率:20.46%
总资产收益率:11.62%
市净率:2.24
市盈率(LYR):14.21

数据加载中...

2026/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/31

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/29

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/16

重要事件披露

Form 8-K - Current report
2026/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/14

重要事件披露

Form 8-K - Current report
2026/04/02

重要事件披露

Form 8-K - Current report
2026/02/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]